Release of fatty acid amides in a patient with hemispheric stroke: A microdialysis study

Stroke

Volumn 33, Issue 8, 2002, Pages 2112-2114

  Schäbitz, Wolf R ^a   Giuffrida, Andrea ^a   Berger, Christian ^a   Aschoff, Alfred ^a   Schwaninger, Markus ^a   Schwab, Stefan ^a   Piomelli, Daniele ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Amides; Cannabinoids; Cerebral ischemia; Fatty acids; Microdialysis; Stroke

Indexed keywords

AMIDE; ANANDAMIDE; ETHANOLAMINE DERIVATIVE; FATTY ACID; GLUTAMIC ACID; LACTIC ACID; OLEYLETHANOLAMIDE; PALMITYLETHANOLAMIDE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE REPORT; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; DISEASE MARKER; HEMISPHERE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHERMIA; MALE; MASS SPECTROMETRY; MEASUREMENT; MICRODIALYSIS; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE; WARMING;

AGED; AMIDES; ARACHIDONIC ACIDS; BRAIN; BRAIN CHEMISTRY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EXTRACELLULAR SPACE; GLUTAMIC ACID; GLYCEROL; HEMIPLEGIA; HUMANS; HYPOTHERMIA, INDUCED; LACTIC ACID; MALE; MICRODIALYSIS; MONITORING, PHYSIOLOGIC; OLEIC ACID; OLEIC ACIDS; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; SLEEP STAGES;

EID: 0036330324     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000023491.63693.18     Document Type: Article

References (23)

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
2. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
3. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
4. Control of pain initiation by endogenous cannabinoids
5. N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation
6. The N-acylationphosphodiesterase pathway and cell signalling
7. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP
8. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
9. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity
10. The endocannabinoid system as a target for therapeutic drugs
11. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death
12. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
13. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
14. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
15. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction
16. Neurometabolic changes during treatment with moderate hypothermia in a patient suffering from severe MCA infarction
17. Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: A microdialysis study
18. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
19. Neurometabolic monitoring of the ischaemic human brain using microdialysis
20. Predictive value of neurochemical monitoring in large middle cerebral artery infarction
21. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage
22. An increase in extracellular glutamate is a sensitive method of detecting ischaemic neuronal damage during cranial base and cerebrovascular surgery: An in vivo microdialysis study
23. Neurochemical monitoring of fatal middle cerebral artery infarction